Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals
- PMID: 28294985
- PMCID: PMC5372947
- DOI: 10.3390/nu9030284
Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals
Abstract
This study evaluated the impact of probiotic supplementation (Lactobacillus rhamnosus CGMCC1.3724 (LPR)) on appetite sensations and eating behaviors in the context of a weight-reducing program. Obese men (n = 45) and women (n = 60) participated in a double-blind, randomized, placebo-controlled trial that included a 12-week weight loss period (Phase 1) based on moderate energy restriction, followed by 12 weeks of weight maintenance (Phase 2). During the two phases of the program, each subject consumed two capsules per day of either a placebo or a LPR formulation (10 mg of LPR equivalent to 1.6 108 CFU/capsule, 210 mg of oligofructose, and 90 mg of inulin). The LPR supplementation increased weight loss in women that was associated with a greater increase in the fasting desire to eat (p = 0.03). On the other hand, satiety efficiency (satiety quotient for desire to eat) at lunch increased (p = 0.02), whereas disinhibition (p = 0.05) and hunger (p = 0.02) scores decreased more in the LPR-treated women, when compared with the female control group. Additionally, the LPR female group displayed a more pronounced decrease in food craving (p = 0.05), and a decrease in the Beck Depression Inventory score (p = 0.05) that was significantly different from the change noted in the placebo group (p = 0.02), as well as a higher score in the Body Esteem Scale questionnaire (p = 0.06). In men, significant benefits of LPR on fasting fullness and cognitive restraint were also observed. Taken together, these observations lend support to the hypothesis that the gut-brain axis may impact appetite control and related behaviors in obesity management.
Keywords: appetite sensations; body weight; eating behaviors; food intake; gut-brain axis; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women.Br J Nutr. 2014 Apr 28;111(8):1507-19. doi: 10.1017/S0007114513003875. Epub 2013 Dec 3. Br J Nutr. 2014. PMID: 24299712 Clinical Trial.
-
Characterization of obese individuals who claim to detect no relationship between their eating pattern and sensations of hunger or fullness.Int J Obes (Lond). 2007 Mar;31(3):435-9. doi: 10.1038/sj.ijo.0803449. Epub 2006 Sep 5. Int J Obes (Lond). 2007. PMID: 16953260
-
The effects of consuming frequent, higher protein meals on appetite and satiety during weight loss in overweight/obese men.Obesity (Silver Spring). 2011 Apr;19(4):818-24. doi: 10.1038/oby.2010.203. Epub 2010 Sep 16. Obesity (Silver Spring). 2011. PMID: 20847729 Free PMC article.
-
Efficacy of Olibra: a 12-week randomized controlled trial and a review of earlier studies.J Diabetes Sci Technol. 2012 May 1;6(3):695-708. doi: 10.1177/193229681200600326. J Diabetes Sci Technol. 2012. PMID: 22768902 Free PMC article. Review.
-
Is reducing appetite beneficial for body weight management in the context of overweight and obesity? A systematic review and meta-analysis from clinical trials assessing body weight management after exposure to satiety enhancing and/or hunger reducing products.Obes Rev. 2019 Jul;20(7):983-997. doi: 10.1111/obr.12854. Epub 2019 Apr 3. Obes Rev. 2019. PMID: 30945414
Cited by
-
Preoperative Multistrain Probiotic Supplementation Does Not Affect Body Weight Changes or Cardiometabolic Risk Factors in Bariatrics: Randomized, Double-Blind, Placebo-Controlled Clinical Trial.Nutrients. 2024 Jun 27;16(13):2055. doi: 10.3390/nu16132055. Nutrients. 2024. PMID: 38999802 Free PMC article. Clinical Trial.
-
Probiotics for the Treatment of Overweight and Obesity in Humans-A Review of Clinical Trials.Microorganisms. 2020 Jul 29;8(8):1148. doi: 10.3390/microorganisms8081148. Microorganisms. 2020. PMID: 32751306 Free PMC article. Review.
-
Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes.Neurosci Biobehav Rev. 2019 Apr;99:160-197. doi: 10.1016/j.neubiorev.2018.11.010. Epub 2018 Nov 22. Neurosci Biobehav Rev. 2019. PMID: 30471308 Free PMC article. Review.
-
Gutted! Unraveling the Role of the Microbiome in Major Depressive Disorder.Harv Rev Psychiatry. 2020 Jan/Feb;28(1):26-39. doi: 10.1097/HRP.0000000000000243. Harv Rev Psychiatry. 2020. PMID: 31913980 Free PMC article. Review.
-
Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials.Neurosci Biobehav Rev. 2019 Jul;102:13-23. doi: 10.1016/j.neubiorev.2019.03.023. Epub 2019 Apr 17. Neurosci Biobehav Rev. 2019. PMID: 31004628 Free PMC article.
References
-
- Da Silva S.T., dos Santos C.A., Bressan J. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutr. Hosp. 2013;28:1039–1048. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical